Valuation Clinuvel Pharmaceuticals Limited OTC Markets

Stocks

Market Closed - OTC Markets Other stock markets 09:31:21 2026-06-10 EDT			5-day change	1st Jan Change
6.100 ^USD	-4.69%		-.--%	-20.78%

07-23	Clinuvel Pharmaceuticals Limited to Reduce Global Workforce by Approximately 10%-20%	CI
07-23	Clinuvel Pharmaceuticals Limited Announces Relocation of Corporate Headquarters to the United States	CI

Data adjusted to current consolidation scope

Fiscal Period: June	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	1,517	733.7	883.5	769.8	520.3	507.3	-	-
Change	-	-51.63%	20.4%	-12.87%	-32.41%	-2.49%	-	-
Enterprise Value (EV) ¹	1,434	612.2	726.6	585.9	296.2	254.7	222.8	187.6
Change	-	-57.31%	18.69%	-19.37%	-49.45%	-14.02%	-12.52%	-15.79%
P/E	63.4x	36.8x	30.3x	22x	14.5x	14.2x	13.4x	10.4x
PBR	15.4x	5.84x	5.37x	3.79x	2.17x	1.85x	1.65x	1.48x
PEG	-	-2.2x	0.6x	1.2x	5.06x	-10.2x	2.27x	0.4x
Capitalization / Revenue	31.6x	11.2x	11.3x	8.73x	5.48x	5.12x	4.84x	3.89x
EV / Revenue	29.9x	9.32x	9.28x	6.64x	3.12x	2.57x	2.13x	1.44x
EV / EBITDA	55x	16.4x	19.5x	12x	6.84x	6.15x	5.01x	3.83x
EV / EBIT	56.8x	16.7x	20x	12.3x	7.03x	6.35x	5.14x	3.91x
EV / FCF	77.9x	15.5x	20.2x	18.6x	7.26x	8.05x	6.12x	3.35x
FCF Yield	1.28%	6.44%	4.94%	5.37%	13.8%	12.4%	16.4%	29.8%
Dividend per Share ²	0.025	0.04	0.05	0.05	0.05	0.0611	0.08	0.2257
Rate of return	0.08%	0.27%	0.28%	0.33%	0.48%	0.61%	0.8%	2.24%
EPS ²	0.484	0.403	0.591	0.698	0.718	0.708	0.7498	0.9713
Distribution rate	5.17%	9.93%	8.46%	7.16%	6.96%	8.64%	10.7%	23.2%
Net sales ¹	47.98	65.72	78.32	88.18	95.02	99.16	104.8	130.5
EBITDA ¹	26.1	37.44	37.2	48.95	43.3	41.42	44.46	48.93
EBIT ¹	25.24	36.68	36.41	47.81	42.12	40.08	43.38	47.94
Net income ¹	24.73	20.88	30.6	35.64	36.17	35.75	37.77	48.95
Net Debt ¹	-82.69	-121.5	-156.8	-183.9	-224.1	-252.6	-284.5	-319.7
Reference price ²	30.70	14.85	17.88	15.37	10.38	10.06	10.06	10.06
Nbr of stocks (in thousands)	49,410	49,410	49,410	50,083	50,124	50,428	-	-
Announcement Date	8/26/21	8/30/22	8/29/23	8/28/24	8/27/25	-	-	-

¹AUD in Million²AUD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
REGENERON PHARMACEUTICALS, INC.	17.35x	3.71x	9.57x	0.59%	66.74B
UCB	26.36x	5.45x	16.03x	0.6%	53.32B
SAMSUNG BIOLOGICS CO.,LTD.	37.26x	12.6x	24.05x	-.--%	48.12B
CSL LIMITED	-42.39x	3.06x	9.03x	3.57%	38.25B
BIOGEN INC.	25.06x	3.49x	11.87x	-.--%	29.85B
INCYTE CORPORATION	56.96x	3.39x	25.31x	-.--%	23.51B
MODERNA, INC.	-6.24x	8.61x	-5.3x	-.--%	21.45B
INNOVENT BIOLOGICS, INC.	64.96x	6.38x	43.91x	-.--%	19.97B
BRIDGEBIO PHARMA, INC.	-37.77x	18x	-49.29x	-.--%	16.47B
Average	15.73x	7.19x	9.46x	0.53%	35.3B
Weighted average by Cap.	16.88x	6.47x	12.27x	0.65%